Literature DB >> 29856562

Long-term antipsychotic treatment of schizophrenia: does it help or hurt over a 20-year period?

Martin Harrow1, Thomas H Jobe1.   

Abstract

Entities:  

Year:  2018        PMID： 29856562      PMCID： PMC5980604          DOI： 10.1002/wps.20518

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  11 in total

1.  Recovery from psychotic illness: a 15- and 25-year international follow-up study.

Authors:  G Harrison; K Hopper; T Craig; E Laska; C Siegel; J Wanderling; K C Dube; K Ganev; R Giel; W an der Heiden; S K Holmberg; A Janca; P W Lee; C A León; S Malhotra; A J Marsella; Y Nakane; N Sartorius; Y Shen; C Skoda; R Thara; S J Tsirkin; V K Varma; D Walsh; D Wiersma
Journal:  Br J Psychiatry       Date:  2001-06       Impact factor: 9.319

2.  Declining Clinical Course of Psychotic Disorders Over the Two Decades Following First Hospitalization: Evidence From the Suffolk County Mental Health Project.

Authors:  Roman Kotov; Laura Fochtmann; Kaiqiao Li; Marsha Tanenberg-Karant; Eduardo A Constantino; Joan Rubinstein; Greg Perlman; Eva Velthorst; Anne-Kathrin J Fett; Gabrielle Carlson; Evelyn J Bromet
Journal:  Am J Psychiatry       Date:  2017-08-04       Impact factor: 18.112

3.  Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis.

Authors:  Regitze Sølling Wils; Ditte Resendal Gotfredsen; Carsten Hjorthøj; Stephen F Austin; Nikolai Albert; Rikke Gry Secher; Anne Amalie Elgaard Thorup; Ole Mors; Merete Nordentoft
Journal:  Schizophr Res       Date:  2016-10-27       Impact factor: 4.939

4.  Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication - a 10-year follow-up of the Northern Finland 1966 Birth Cohort study.

Authors:  J Moilanen; M Haapea; J Miettunen; E Jääskeläinen; J Veijola; M Isohanni; H Koponen
Journal:  Eur Psychiatry       Date:  2011-09-14       Impact factor: 5.361

5.  Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia.

Authors:  Tomotaka Suzuki; Nobuhisa Kanahara; Hiroshi Yamanaka; Masayuki Takase; Hiroshi Kimura; Hiroyuki Watanabe; Masaomi Iyo
Journal:  Psychiatry Res       Date:  2015-03-31       Impact factor: 3.222

6.  Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial.

Authors:  Lex Wunderink; Roeline M Nieboer; Durk Wiersma; Sjoerd Sytema; Fokko J Nienhuis
Journal:  JAMA Psychiatry       Date:  2013-09       Impact factor: 21.596

7.  A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia.

Authors:  Martin Harrow; Thomas H Jobe; Robert N Faull; Jie Yang
Journal:  Psychiatry Res       Date:  2017-06-22       Impact factor: 3.222

8.  Different outcomes of never-treated and treated patients with schizophrenia: 14-year follow-up study in rural China.

Authors:  Mao-Sheng Ran; Xue Weng; Cecilia Lai-Wan Chan; Eric Yu-Hai Chen; Cui-Ping Tang; Fu-Rong Lin; Wen-Jun Mao; Shi-Hui Hu; Yue-Qin Huang; Meng-Ze Xiang
Journal:  Br J Psychiatry       Date:  2015-09-17       Impact factor: 9.319

9.  Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study.

Authors:  C Morgan; J Lappin; M Heslin; K Donoghue; B Lomas; U Reininghaus; A Onyejiaka; T Croudace; P B Jones; R M Murray; P Fearon; G A Doody; P Dazzan
Journal:  Psychol Med       Date:  2014-02-26       Impact factor: 7.723

10.  Dopamine supersensitivity psychosis and dopamine partial agonist: a retrospective survey of failure of switching to aripiprazole in schizophrenia.

Authors:  Masayuki Takase; Nobuhisa Kanahara; Yasunori Oda; Hiroshi Kimura; Hiroyuki Watanabe; Masaomi Iyo
Journal:  J Psychopharmacol       Date:  2015-03-03       Impact factor: 4.153
View more
  4 in total

Review 1.  Achieving the Lowest Effective Antipsychotic Dose for Patients with Remitted Psychosis: A Proposed Guided Dose-Reduction Algorithm.

Authors:  Chen-Chung Liu; Hiroyoshi Takeuchi
Journal:  CNS Drugs       Date:  2020-02       Impact factor: 5.749

2.  A Real-World Observation of Antipsychotic Effects on Brain Volumes and Intrinsic Brain Activity in Schizophrenia.

Authors:  Yifan Chen; Fay Y Womer; Ruiqi Feng; Xizhe Zhang; Yanbo Zhang; Jia Duan; Miao Chang; Zhiyang Yin; Xiaowei Jiang; Shengnan Wei; Yange Wei; Yanqing Tang; Fei Wang
Journal:  Front Neurosci       Date:  2022-02-09       Impact factor: 4.677

3.  Reconceptualizing Psychosis: The Hearing Voices Movement and Social Approaches to Health.

Authors:  Rory Neirin Higgs
Journal:  Health Hum Rights       Date:  2020-06

4.  Antipsychotic Effects on Cortical Morphology in Schizophrenia and Bipolar Disorders.

Authors:  Ruiqi Feng; Fay Y Womer; E Kale Edmiston; Yifan Chen; Yinshan Wang; Miao Chang; Zhiyang Yin; Yange Wei; Jia Duan; Sihua Ren; Chao Li; Zhuang Liu; Xiaowei Jiang; Shengnan Wei; Songbai Li; Xizhe Zhang; Xi-Nian Zuo; Yanqing Tang; Fei Wang
Journal:  Front Neurosci       Date:  2020-12-10       Impact factor: 4.677
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.